Post-earnings recap
Reported
Tue, May 8, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Despite missing EPS expectations, Haemonetics Corp's stock rose by 5.79% following the earnings report. This increase may reflect investor confidence in the company's long-term strategy and management's focus on operational improvements. The lack of revenue data and guidance leaves some uncertainty, but the positive stock reaction suggests that investors are willing to look past the EPS miss for now.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.43 | N/A | -8.67% |
Management expressed a cautious optimism about future growth. They highlighted ongoing efforts to enhance operational efficiency.
We are focused on improving our operational efficiency.
Our long-term strategy remains intact despite current challenges.